GeNeuro: Recent Study Demonstrates the Strong Link Between S

11.09.2023 - Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing treatments for neurodegenerative and autoimmune diseases, such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe ... Seite 1

Related Keywords

Paris , France General , France , Italy , United States , , Psychiatry Department Of The Cr , Schizophrenia International Research Society , Robert Yolken Johns Hopkins University , Psychiatry Department , Robert Yolken , Johns Hopkins University , Geneuro Porteur Chart , Eneuro Porteur Kurs , Eneuro Porteur Aktie ,